The WACC of Seoul Pharma Co Ltd (018680.KQ) is 5.9%.
| Range | Selected | |
| Cost of equity | 5.30% - 7.10% | 6.20% |
| Tax rate | 9.20% - 15.50% | 12.35% |
| Cost of debt | 4.00% - 8.30% | 6.15% |
| WACC | 4.7% - 7.0% | 5.9% |
| Category | Low | High |
| Long-term bond rate | 3.1% | 3.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.38 | 0.44 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.30% | 7.10% |
| Tax rate | 9.20% | 15.50% |
| Debt/Equity ratio | 0.56 | 0.56 |
| Cost of debt | 4.00% | 8.30% |
| After-tax WACC | 4.7% | 7.0% |
| Selected WACC | 5.9% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 018680.KQ:
cost_of_equity (6.20%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.38) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.